BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Relmada Therapeutics Inc.

Headquarters: New York, NY, United States
Year Founded: 2004
Status: Public
Industry Sector: HealthTechnology
CEO: Sergio Traversa, PhD, MBA
Number Of Employees: 17
Enterprise Value: $-29,224,231
PE Ratio: -0.13
Exchange/Ticker 1: NASDAQ:RLMD
Exchange/Ticker 2: N/A
Latest Market Cap: $11,607,100